CUSIP: 092528207
Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / ISHARES INTERMED
-
Total 13F shares
-
845,438
-
Share change
-
+359,640
-
Total reported value
-
$20,356,047
-
Price per share
-
$24.08
-
Number of holders
-
24
-
Value change
-
+$8,657,997
-
Number of buys
-
15
-
Number of sells
-
7
Security key
092528207
Report period
Q3 2024
Institutions
24
Top holders
10
Reporting periods
Holder history for CUSIP 092528207
Recent filing periods:
Top shareholders of INMU - BLACKROCK ETF TRUST II - ISHARES INTERMED (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of BLACKROCK ETF TRUST II - ISHARES INTERMED (INMU) as of Q3 2024
As of 30 Sep 2024,
BLACKROCK ETF TRUST II - ISHARES INTERMED (INMU) was held by
24 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
845,438 shares.
The largest 10 holders included
FORTE ASSET MANAGEMENT LLC, HighTower Advisors, LLC, StoneCrest Wealth Management, Inc., JANE STREET GROUP, LLC, NewEdge Advisors, LLC, Cetera Investment Advisers, SimpliFi, Inc., Cyr Financial Inc., Belpointe Asset Management LLC, and Savvy Advisors, Inc..
This page lists
24
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
Compare Q3 2024 vs Q2 2024 Across Filers
| Investor |
Q2 2024 Shares |
Q3 2024 Shares |
Share Diff |
Share Chg % |
Q2 2024 Value $ |
Q3 2024 Value $ |
Value Diff $ |
Value Chg % |
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.